It only took about 48 hours for the Huskies and coach Jedd Fisch to see some rewards for the large recruiting weekend they just hosted. Isaiah Leilua, a 6-foot, 220-pound linebacker from Southern ...

The Mizzou football team landed its first defensive commit from the Class of 2027 in the form of safety Jabarri Lofton, according to Rivals.com. Lofton is a three-star prospect from East St. Louis ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The partners gain preferred ...

The General Services Administration has unveiled the first phase of awards under the Alliant 3 governmentwide acquisition contract, a multiple-award vehicle supporting federal IT modernization. The ...

If the rumors are true, anybody who’s an NBA fan does not want to miss next year’s Three-Point Contest during NBA All-Star Weekend. Stephen Curry #30 of the Golden State Warriors shoots a three-point ...

When Ben Rosenfeld started working as a residential assistant at a Stanford University dorm, he encountered 77 freshmen possessed by an “all-consuming” force. His new gig coincided with the release of ...

It’s a matchup that could’ve happened at the N.J. Catholic School Duals, but the regular-season best was saved for last on Thursday in Jersey City. NJ.com No. 3-ranked Christian Brothers visited No. 2 ...

The writing was on the wall once 2027 cornerback Dolph McDonald decommitted from Colorado over a week ago. Xavier McDonald, a three-star wide receiver prospect in the 2026 class and brother to Dolph, ...

Alabama basketball's 2026 recruiting class has a new member after the commitment of Qayden Samuels. The 6-foot-5, 5-star forward out of Bishop McNamara in Maryland rolled with the Crimson Tide ...

Syracuse, N.Y. — Syracuse has received a commitment from 2027 athlete Sa’Nir Brooks, he announced Saturday. Brooks plays running back and strong safety for national powerhouse St. Frances (Baltimore), ...

Sanofi has reported mixed phase 3 data on amlitelimab, further muddying the prospects of a molecule tipped to generate blockbuster sales. But, with hits among the misses, the French drugmaker plans to ...